nodes	percent_of_prediction	percent_of_DWPC	metapath
Alosetron—CYP1A2—Carmustine—malignant glioma	0.454	0.57	CbGbCtD
Alosetron—CYP3A4—Temozolomide—malignant glioma	0.343	0.43	CbGbCtD
Alosetron—HTR3A—fourth ventricle—malignant glioma	0.0577	0.733	CbGeAlD
Alosetron—HTR3A—brainstem—malignant glioma	0.00452	0.0574	CbGeAlD
Alosetron—HTR3A—telencephalon—malignant glioma	0.00401	0.051	CbGeAlD
Alosetron—Haemorrhoids—Temozolomide—malignant glioma	0.00242	0.0552	CcSEcCtD
Alosetron—HTR3A—central nervous system—malignant glioma	0.00228	0.029	CbGeAlD
Alosetron—Burning sensation—Carmustine—malignant glioma	0.00212	0.0483	CcSEcCtD
Alosetron—CYP2E1—telencephalon—malignant glioma	0.00186	0.0237	CbGeAlD
Alosetron—HTR3A—brain—malignant glioma	0.00181	0.023	CbGeAlD
Alosetron—Drug interaction—Carmustine—malignant glioma	0.00159	0.0362	CcSEcCtD
Alosetron—CYP2E1—medulla oblongata—malignant glioma	0.00146	0.0186	CbGeAlD
Alosetron—CYP2E1—spinal cord—malignant glioma	0.00131	0.0166	CbGeAlD
Alosetron—Gastroenteritis—Temozolomide—malignant glioma	0.00117	0.0266	CcSEcCtD
Alosetron—Injury—Carmustine—malignant glioma	0.00116	0.0265	CcSEcCtD
Alosetron—CYP2E1—central nervous system—malignant glioma	0.00106	0.0134	CbGeAlD
Alosetron—CYP2E1—cerebellum—malignant glioma	0.00103	0.0131	CbGeAlD
Alosetron—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.000911	0.0208	CcSEcCtD
Alosetron—Abdominal distension—Temozolomide—malignant glioma	0.000899	0.0205	CcSEcCtD
Alosetron—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.000865	0.0107	CbGpPWpGaD
Alosetron—CYP3A4—central nervous system—malignant glioma	0.000852	0.0108	CbGeAlD
Alosetron—CYP2E1—brain—malignant glioma	0.000841	0.0107	CbGeAlD
Alosetron—CYP2E1—Tryptophan metabolism—CYP2C18—malignant glioma	0.000837	0.0103	CbGpPWpGaD
Alosetron—Hyperglycaemia—Carmustine—malignant glioma	0.000833	0.019	CcSEcCtD
Alosetron—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00083	0.0189	CcSEcCtD
Alosetron—Pollakiuria—Temozolomide—malignant glioma	0.000825	0.0188	CcSEcCtD
Alosetron—Depression—Carmustine—malignant glioma	0.000821	0.0187	CcSEcCtD
Alosetron—CYP1A2—Tryptophan metabolism—ASMT—malignant glioma	0.000815	0.0101	CbGpPWpGaD
Alosetron—Hyperglycaemia—Temozolomide—malignant glioma	0.000805	0.0184	CcSEcCtD
Alosetron—Urinary tract infection—Carmustine—malignant glioma	0.000801	0.0183	CcSEcCtD
Alosetron—Depression—Temozolomide—malignant glioma	0.000794	0.0181	CcSEcCtD
Alosetron—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000781	0.00963	CbGpPWpGaD
Alosetron—Urinary tract infection—Temozolomide—malignant glioma	0.000774	0.0176	CcSEcCtD
Alosetron—CYP2E1—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000771	0.0095	CbGpPWpGaD
Alosetron—CYP3A4—Xenobiotics—CYP2C18—malignant glioma	0.000756	0.00933	CbGpPWpGaD
Alosetron—Sinusitis—Temozolomide—malignant glioma	0.000747	0.017	CcSEcCtD
Alosetron—Haemoglobin—Carmustine—malignant glioma	0.000743	0.017	CcSEcCtD
Alosetron—Haemorrhage—Carmustine—malignant glioma	0.00074	0.0169	CcSEcCtD
Alosetron—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.000739	0.00912	CbGpPWpGaD
Alosetron—Hypoaesthesia—Carmustine—malignant glioma	0.000736	0.0168	CcSEcCtD
Alosetron—HTR3A—SIDS Susceptibility Pathways—YWHAE—malignant glioma	0.000726	0.00896	CbGpPWpGaD
Alosetron—HTR3A—SIDS Susceptibility Pathways—NTRK2—malignant glioma	0.000726	0.00896	CbGpPWpGaD
Alosetron—Haemoglobin—Temozolomide—malignant glioma	0.000718	0.0164	CcSEcCtD
Alosetron—Hepatitis—Temozolomide—malignant glioma	0.000715	0.0163	CcSEcCtD
Alosetron—Haemorrhage—Temozolomide—malignant glioma	0.000715	0.0163	CcSEcCtD
Alosetron—Hypoaesthesia—Temozolomide—malignant glioma	0.000711	0.0162	CcSEcCtD
Alosetron—CYP3A4—Irinotecan Pathway—BCHE—malignant glioma	0.000709	0.00874	CbGpPWpGaD
Alosetron—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000677	0.00835	CbGpPWpGaD
Alosetron—CYP2E1—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000668	0.00824	CbGpPWpGaD
Alosetron—Arrhythmia—Carmustine—malignant glioma	0.000661	0.0151	CcSEcCtD
Alosetron—Alopecia—Carmustine—malignant glioma	0.000654	0.0149	CcSEcCtD
Alosetron—HTR3A—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000646	0.00796	CbGpPWpGaD
Alosetron—CYP2E1—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000633	0.00781	CbGpPWpGaD
Alosetron—Alopecia—Temozolomide—malignant glioma	0.000632	0.0144	CcSEcCtD
Alosetron—CYP3A4—Tryptophan metabolism—ASMT—malignant glioma	0.000629	0.00776	CbGpPWpGaD
Alosetron—Tremor—Carmustine—malignant glioma	0.000603	0.0138	CcSEcCtD
Alosetron—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.000599	0.00739	CbGpPWpGaD
Alosetron—HTR3A—SIDS Susceptibility Pathways—GJA1—malignant glioma	0.000597	0.00736	CbGpPWpGaD
Alosetron—HTR3A—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000591	0.00728	CbGpPWpGaD
Alosetron—Tremor—Temozolomide—malignant glioma	0.000583	0.0133	CcSEcCtD
Alosetron—Ill-defined disorder—Temozolomide—malignant glioma	0.000577	0.0132	CcSEcCtD
Alosetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.000571	0.00704	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—malignant glioma	0.000565	0.00697	CbGpPWpGaD
Alosetron—Malaise—Temozolomide—malignant glioma	0.000561	0.0128	CcSEcCtD
Alosetron—Hypertension—Carmustine—malignant glioma	0.000556	0.0127	CcSEcCtD
Alosetron—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000549	0.00678	CbGpPWpGaD
Alosetron—CYP2E1—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000549	0.00677	CbGpPWpGaD
Alosetron—Myalgia—Carmustine—malignant glioma	0.000548	0.0125	CcSEcCtD
Alosetron—Anxiety—Carmustine—malignant glioma	0.000546	0.0125	CcSEcCtD
Alosetron—Cough—Temozolomide—malignant glioma	0.000543	0.0124	CcSEcCtD
Alosetron—CYP2C9—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000542	0.00669	CbGpPWpGaD
Alosetron—Hypertension—Temozolomide—malignant glioma	0.000537	0.0122	CcSEcCtD
Alosetron—Confusional state—Carmustine—malignant glioma	0.00053	0.0121	CcSEcCtD
Alosetron—Myalgia—Temozolomide—malignant glioma	0.00053	0.0121	CcSEcCtD
Alosetron—Anxiety—Temozolomide—malignant glioma	0.000528	0.012	CcSEcCtD
Alosetron—Discomfort—Temozolomide—malignant glioma	0.000523	0.0119	CcSEcCtD
Alosetron—Infection—Carmustine—malignant glioma	0.000522	0.0119	CcSEcCtD
Alosetron—HTR3A—SIDS Susceptibility Pathways—HES1—malignant glioma	0.00052	0.00642	CbGpPWpGaD
Alosetron—Dry mouth—Temozolomide—malignant glioma	0.000518	0.0118	CcSEcCtD
Alosetron—HTR3A—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000516	0.00637	CbGpPWpGaD
Alosetron—Confusional state—Temozolomide—malignant glioma	0.000512	0.0117	CcSEcCtD
Alosetron—Infection—Temozolomide—malignant glioma	0.000504	0.0115	CcSEcCtD
Alosetron—CYP1A2—Tryptophan metabolism—CYP2C18—malignant glioma	0.000503	0.00621	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor—NF1—malignant glioma	0.000503	0.00621	CbGpPWpGaD
Alosetron—HTR3A—Transmembrane transport of small molecules—APOD—malignant glioma	0.000502	0.00619	CbGpPWpGaD
Alosetron—Skin disorder—Temozolomide—malignant glioma	0.000493	0.0112	CcSEcCtD
Alosetron—Hyperhidrosis—Temozolomide—malignant glioma	0.000491	0.0112	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000479	0.0109	CcSEcCtD
Alosetron—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000476	0.00587	CbGpPWpGaD
Alosetron—CYP2C9—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.00047	0.0058	CbGpPWpGaD
Alosetron—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000469	0.00579	CbGpPWpGaD
Alosetron—CYP1A2—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000463	0.00571	CbGpPWpGaD
Alosetron—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000463	0.0105	CcSEcCtD
Alosetron—CYP2E1—Tryptophan metabolism—CAT—malignant glioma	0.000457	0.00563	CbGpPWpGaD
Alosetron—Pain—Carmustine—malignant glioma	0.000449	0.0102	CcSEcCtD
Alosetron—Constipation—Carmustine—malignant glioma	0.000449	0.0102	CcSEcCtD
Alosetron—CYP2C9—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000445	0.00549	CbGpPWpGaD
Alosetron—Fatigue—Temozolomide—malignant glioma	0.000438	0.00998	CcSEcCtD
Alosetron—HTR3A—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.000436	0.00538	CbGpPWpGaD
Alosetron—Constipation—Temozolomide—malignant glioma	0.000434	0.0099	CcSEcCtD
Alosetron—Pain—Temozolomide—malignant glioma	0.000434	0.0099	CcSEcCtD
Alosetron—Feeling abnormal—Carmustine—malignant glioma	0.000433	0.00987	CcSEcCtD
Alosetron—Feeling abnormal—Temozolomide—malignant glioma	0.000418	0.00954	CcSEcCtD
Alosetron—CYP2C9—Arachidonic acid metabolism—PTGS1—malignant glioma	0.000418	0.00515	CbGpPWpGaD
Alosetron—CYP2E1—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000416	0.00513	CbGpPWpGaD
Alosetron—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000407	0.00502	CbGpPWpGaD
Alosetron—Urticaria—Temozolomide—malignant glioma	0.000403	0.0092	CcSEcCtD
Alosetron—CYP1A2—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000402	0.00495	CbGpPWpGaD
Alosetron—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000394	0.00486	CbGpPWpGaD
Alosetron—CYP3A4—Tryptophan metabolism—CYP2C18—malignant glioma	0.000388	0.00479	CbGpPWpGaD
Alosetron—Hypersensitivity—Carmustine—malignant glioma	0.000387	0.00883	CcSEcCtD
Alosetron—CYP2C9—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000386	0.00476	CbGpPWpGaD
Alosetron—CYP3A4—Irinotecan Pathway—APC—malignant glioma	0.000385	0.00475	CbGpPWpGaD
Alosetron—CYP1A2—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000381	0.00469	CbGpPWpGaD
Alosetron—Asthenia—Carmustine—malignant glioma	0.000377	0.0086	CcSEcCtD
Alosetron—Hypersensitivity—Temozolomide—malignant glioma	0.000374	0.00853	CcSEcCtD
Alosetron—Asthenia—Temozolomide—malignant glioma	0.000364	0.00831	CcSEcCtD
Alosetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000362	0.00447	CbGpPWpGaD
Alosetron—CYP3A4—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000358	0.00441	CbGpPWpGaD
Alosetron—CYP1A2—Arachidonic acid metabolism—PTGS1—malignant glioma	0.000357	0.0044	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—malignant glioma	0.000355	0.00437	CbGpPWpGaD
Alosetron—CYP2E1—Biological oxidations—CYP2B6—malignant glioma	0.000336	0.00415	CbGpPWpGaD
Alosetron—Vomiting—Carmustine—malignant glioma	0.000334	0.00762	CcSEcCtD
Alosetron—CYP2E1—Metapathway biotransformation—CYP2B6—malignant glioma	0.000332	0.00409	CbGpPWpGaD
Alosetron—Rash—Carmustine—malignant glioma	0.000331	0.00756	CcSEcCtD
Alosetron—Dermatitis—Carmustine—malignant glioma	0.000331	0.00755	CcSEcCtD
Alosetron—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.00033	0.00407	CbGpPWpGaD
Alosetron—Headache—Carmustine—malignant glioma	0.000329	0.00751	CcSEcCtD
Alosetron—Vomiting—Temozolomide—malignant glioma	0.000323	0.00736	CcSEcCtD
Alosetron—Rash—Temozolomide—malignant glioma	0.00032	0.0073	CcSEcCtD
Alosetron—Dermatitis—Temozolomide—malignant glioma	0.00032	0.00729	CcSEcCtD
Alosetron—Headache—Temozolomide—malignant glioma	0.000318	0.00725	CcSEcCtD
Alosetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000314	0.00387	CbGpPWpGaD
Alosetron—CYP1A2—Estrogen Receptor Pathway—STAT3—malignant glioma	0.000313	0.00387	CbGpPWpGaD
Alosetron—Nausea—Carmustine—malignant glioma	0.000312	0.00712	CcSEcCtD
Alosetron—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.00031	0.00382	CbGpPWpGaD
Alosetron—Nausea—Temozolomide—malignant glioma	0.000302	0.00688	CcSEcCtD
Alosetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000294	0.00362	CbGpPWpGaD
Alosetron—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000293	0.00361	CbGpPWpGaD
Alosetron—HTR3A—Ion channel transport—RAF1—malignant glioma	0.000293	0.00361	CbGpPWpGaD
Alosetron—CYP2E1—Biological oxidations—CYP2C18—malignant glioma	0.000292	0.0036	CbGpPWpGaD
Alosetron—CYP2E1—Metapathway biotransformation—CYP2C18—malignant glioma	0.000288	0.00355	CbGpPWpGaD
Alosetron—HTR3A—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000283	0.00349	CbGpPWpGaD
Alosetron—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000277	0.00342	CbGpPWpGaD
Alosetron—CYP1A2—Tryptophan metabolism—CAT—malignant glioma	0.000275	0.00339	CbGpPWpGaD
Alosetron—HTR3A—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000271	0.00335	CbGpPWpGaD
Alosetron—HTR3A—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000271	0.00334	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—malignant glioma	0.000261	0.00322	CbGpPWpGaD
Alosetron—HTR3A—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000257	0.00317	CbGpPWpGaD
Alosetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000255	0.00314	CbGpPWpGaD
Alosetron—CYP2E1—Tryptophan metabolism—MDM2—malignant glioma	0.000252	0.00311	CbGpPWpGaD
Alosetron—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.00025	0.00308	CbGpPWpGaD
Alosetron—CYP1A2—Phase II conjugation—GSTT1—malignant glioma	0.000242	0.00299	CbGpPWpGaD
Alosetron—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000237	0.00292	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—CYP2B6—malignant glioma	0.000237	0.00292	CbGpPWpGaD
Alosetron—HTR3A—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000236	0.00291	CbGpPWpGaD
Alosetron—CYP2E1—Biological oxidations—GSTT1—malignant glioma	0.000236	0.00291	CbGpPWpGaD
Alosetron—CYP2C9—Metapathway biotransformation—CYP2B6—malignant glioma	0.000233	0.00288	CbGpPWpGaD
Alosetron—HTR3A—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.00023	0.00283	CbGpPWpGaD
Alosetron—HTR3A—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000225	0.00277	CbGpPWpGaD
Alosetron—CYP2E1—Biological oxidations—PTGS1—malignant glioma	0.000221	0.00273	CbGpPWpGaD
Alosetron—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000212	0.00261	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—CYP2C18—malignant glioma	0.000205	0.00253	CbGpPWpGaD
Alosetron—CYP2C9—Metapathway biotransformation—CYP2C18—malignant glioma	0.000202	0.00249	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—CYP2B6—malignant glioma	0.000202	0.00249	CbGpPWpGaD
Alosetron—CYP1A2—Metapathway biotransformation—CYP2B6—malignant glioma	0.000199	0.00246	CbGpPWpGaD
Alosetron—HTR3A—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000197	0.00243	CbGpPWpGaD
Alosetron—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000193	0.00238	CbGpPWpGaD
Alosetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000183	0.00225	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—CYP2C18—malignant glioma	0.000175	0.00216	CbGpPWpGaD
Alosetron—CYP1A2—Metapathway biotransformation—CYP2C18—malignant glioma	0.000173	0.00213	CbGpPWpGaD
Alosetron—CYP1A2—Phase II conjugation—GSTP1—malignant glioma	0.000168	0.00207	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—GSTT1—malignant glioma	0.000166	0.00205	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—RTEL1—malignant glioma	0.000165	0.00204	CbGpPWpGaD
Alosetron—CYP2E1—Biological oxidations—GSTP1—malignant glioma	0.000163	0.00202	CbGpPWpGaD
Alosetron—CYP2E1—Metapathway biotransformation—GSTP1—malignant glioma	0.000161	0.00199	CbGpPWpGaD
Alosetron—CYP2C9—Arachidonic acid metabolism—PTGS2—malignant glioma	0.00016	0.00197	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000156	0.00192	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—PTGS1—malignant glioma	0.000155	0.00192	CbGpPWpGaD
Alosetron—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.000154	0.0019	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malignant glioma	0.000152	0.00188	CbGpPWpGaD
Alosetron—CYP1A2—Tryptophan metabolism—MDM2—malignant glioma	0.000152	0.00187	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	0.000151	0.00186	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—malignant glioma	0.000146	0.0018	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—GSTT1—malignant glioma	0.000142	0.00175	CbGpPWpGaD
Alosetron—CYP1A2—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000137	0.00169	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malignant glioma	0.000136	0.00168	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malignant glioma	0.000136	0.00167	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000135	0.00167	CbGpPWpGaD
Alosetron—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000133	0.00165	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—PTGS1—malignant glioma	0.000133	0.00164	CbGpPWpGaD
Alosetron—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000117	0.00144	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—RTEL1—malignant glioma	0.000116	0.00143	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	0.000115	0.00142	CbGpPWpGaD
Alosetron—CYP2C9—Biological oxidations—GSTP1—malignant glioma	0.000115	0.00142	CbGpPWpGaD
Alosetron—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	0.000113	0.0014	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000109	0.00135	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	0.000106	0.00131	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	0.000104	0.00128	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	0.000104	0.00128	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000103	0.00126	CbGpPWpGaD
Alosetron—HTR3A—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000102	0.00126	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—RTEL1—malignant glioma	9.93e-05	0.00123	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	9.87e-05	0.00122	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	9.87e-05	0.00122	CbGpPWpGaD
Alosetron—CYP1A2—Biological oxidations—GSTP1—malignant glioma	9.82e-05	0.00121	CbGpPWpGaD
Alosetron—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	9.79e-05	0.00121	CbGpPWpGaD
Alosetron—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	9.69e-05	0.0012	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—COX8A—malignant glioma	9.49e-05	0.00117	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	8.31e-05	0.00102	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ASMT—malignant glioma	8.07e-05	0.000995	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	8.04e-05	0.000992	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—RTEL1—malignant glioma	7.67e-05	0.000946	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—BCAN—malignant glioma	7.59e-05	0.000936	CbGpPWpGaD
Alosetron—CYP3A4—Biological oxidations—GSTP1—malignant glioma	7.58e-05	0.000935	CbGpPWpGaD
Alosetron—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	7.48e-05	0.000922	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	7.1e-05	0.000876	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	6.87e-05	0.000847	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—COX8A—malignant glioma	6.68e-05	0.000824	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—IDH2—malignant glioma	6.12e-05	0.000754	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	5.97e-05	0.000736	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CYP2B6—malignant glioma	5.75e-05	0.000709	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—COX8A—malignant glioma	5.71e-05	0.000704	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ASMT—malignant glioma	5.68e-05	0.0007	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	5.55e-05	0.000684	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—BCAN—malignant glioma	5.34e-05	0.000658	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—IDH1—malignant glioma	5.26e-05	0.000649	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	5.1e-05	0.000629	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—SPHK1—malignant glioma	5.09e-05	0.000628	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CYP2C18—malignant glioma	4.99e-05	0.000615	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ASMT—malignant glioma	4.85e-05	0.000598	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	4.74e-05	0.000585	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—BCAN—malignant glioma	4.56e-05	0.000563	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—COX8A—malignant glioma	4.4e-05	0.000543	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—IDH2—malignant glioma	4.3e-05	0.000531	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.06e-05	0.0005	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CYP2B6—malignant glioma	4.05e-05	0.000499	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GSTT1—malignant glioma	4.03e-05	0.000497	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PTGS1—malignant glioma	3.78e-05	0.000466	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ASMT—malignant glioma	3.74e-05	0.000462	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—IDH1—malignant glioma	3.7e-05	0.000456	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—IDH2—malignant glioma	3.68e-05	0.000453	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—SPHK1—malignant glioma	3.58e-05	0.000442	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—BCAN—malignant glioma	3.52e-05	0.000434	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—BCHE—malignant glioma	3.51e-05	0.000433	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CYP2C18—malignant glioma	3.51e-05	0.000433	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—SLC5A5—malignant glioma	3.47e-05	0.000428	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.47e-05	0.000428	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CYP2B6—malignant glioma	3.46e-05	0.000426	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.31e-05	0.000408	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—IDH1—malignant glioma	3.16e-05	0.00039	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—SPHK1—malignant glioma	3.06e-05	0.000377	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.01e-05	0.000372	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CYP2C18—malignant glioma	3e-05	0.00037	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.91e-05	0.000359	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—IDH2—malignant glioma	2.84e-05	0.00035	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTT1—malignant glioma	2.84e-05	0.00035	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.83e-05	0.000349	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GSTP1—malignant glioma	2.79e-05	0.000345	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CAT—malignant glioma	2.72e-05	0.000335	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CYP2B6—malignant glioma	2.67e-05	0.000329	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PTGS1—malignant glioma	2.66e-05	0.000328	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.65e-05	0.000327	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.57e-05	0.000318	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—NCOR1—malignant glioma	2.57e-05	0.000317	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.48e-05	0.000306	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—BCHE—malignant glioma	2.47e-05	0.000305	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—SLC5A5—malignant glioma	2.44e-05	0.000301	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—IDH1—malignant glioma	2.44e-05	0.000301	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTT1—malignant glioma	2.42e-05	0.000299	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—SPHK1—malignant glioma	2.36e-05	0.000291	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CYP2C18—malignant glioma	2.31e-05	0.000285	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.31e-05	0.000285	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.29e-05	0.000282	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PTGS1—malignant glioma	2.27e-05	0.00028	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.26e-05	0.000279	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—BCHE—malignant glioma	2.11e-05	0.00026	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CAV1—malignant glioma	2.09e-05	0.000258	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—SLC5A5—malignant glioma	2.09e-05	0.000257	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.99e-05	0.000246	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.97e-05	0.000243	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTP1—malignant glioma	1.97e-05	0.000243	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.95e-05	0.000241	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CAT—malignant glioma	1.91e-05	0.000236	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PIK3CG—malignant glioma	1.91e-05	0.000235	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTT1—malignant glioma	1.87e-05	0.000231	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PPARG—malignant glioma	1.84e-05	0.000227	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—NCOR1—malignant glioma	1.81e-05	0.000223	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PTGS1—malignant glioma	1.75e-05	0.000216	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.7e-05	0.00021	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTP1—malignant glioma	1.68e-05	0.000207	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PIK3CD—malignant glioma	1.68e-05	0.000207	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CAT—malignant glioma	1.63e-05	0.000202	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—BCHE—malignant glioma	1.63e-05	0.000201	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.61e-05	0.000199	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—NCOR1—malignant glioma	1.54e-05	0.00019	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CAV1—malignant glioma	1.47e-05	0.000182	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PIK3CB—malignant glioma	1.46e-05	0.00018	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PTGS2—malignant glioma	1.45e-05	0.000179	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.41e-05	0.000174	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PIK3CG—malignant glioma	1.34e-05	0.000165	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTP1—malignant glioma	1.3e-05	0.00016	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PPARG—malignant glioma	1.29e-05	0.00016	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PTEN—malignant glioma	1.26e-05	0.000156	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CAT—malignant glioma	1.26e-05	0.000156	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CAV1—malignant glioma	1.26e-05	0.000155	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.2e-05	0.000148	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—NCOR1—malignant glioma	1.19e-05	0.000147	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PIK3CD—malignant glioma	1.18e-05	0.000145	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PIK3CG—malignant glioma	1.15e-05	0.000141	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PPARG—malignant glioma	1.11e-05	0.000136	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PIK3CB—malignant glioma	1.03e-05	0.000127	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PTGS2—malignant glioma	1.02e-05	0.000126	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PIK3CD—malignant glioma	1.01e-05	0.000124	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CAV1—malignant glioma	9.71e-06	0.00012	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PIK3CA—malignant glioma	8.91e-06	0.00011	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PTEN—malignant glioma	8.88e-06	0.00011	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PIK3CG—malignant glioma	8.85e-06	0.000109	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PIK3CB—malignant glioma	8.78e-06	0.000108	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PTGS2—malignant glioma	8.7e-06	0.000107	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PPARG—malignant glioma	8.54e-06	0.000105	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PIK3CD—malignant glioma	7.78e-06	9.59e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PTEN—malignant glioma	7.59e-06	9.36e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—AKT1—malignant glioma	7.28e-06	8.98e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PIK3CB—malignant glioma	6.78e-06	8.36e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PTGS2—malignant glioma	6.72e-06	8.29e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PIK3CA—malignant glioma	6.27e-06	7.73e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PTEN—malignant glioma	5.86e-06	7.23e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PIK3CA—malignant glioma	5.36e-06	6.61e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—AKT1—malignant glioma	5.12e-06	6.31e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—AKT1—malignant glioma	4.37e-06	5.4e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PIK3CA—malignant glioma	4.13e-06	5.1e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—AKT1—malignant glioma	3.38e-06	4.16e-05	CbGpPWpGaD
